Marlous R. Dillingh

Recombinant human serum amyloid P in healthy volunteers and patients with pulmonary fibrosis

Marlous R. Dillingh, Bernt van den Blink, Matthijs Moerland et al. · Pulmonary Pharmacology & Therapeutics · 2013 · 98 citations

Advanced Lung Disease, Healthy Volunteers, Pulmonary Alveolar Proteinosis +6

Recombinant human pentraxin-2 therapy in patients with idiopathic pulmonary fibrosis: safety, pharmacokinetics and exploratory efficacy

Bernt van den Blink, Marlous R. Dillingh, Leo C. Ginns et al. · European Respiratory Journal · 2016 · 96 citations · Full text

Characterization of inflammation and immune cell modulation induced by low-dose LPS administration to healthy volunteers

Marlous R. Dillingh, Eveline P. van Poelgeest, Karen E. Malone et al. · Journal of Inflammation · 2014 · 55 citations · Full text

Characterization of immune cell, endothelial, and renal responses upon experimental human endotoxemia

Eveline P. van Poelgeest, Marlous R. Dillingh, Marieke de Kam et al. · Journal of Pharmacological and Toxicological Methods · 2017 · 24 citations

Endothelial Cell Pathobiology, Inflammation, Experimental Human Endotoxemia +14

Topical ionic contra‐viral therapy comprised of digoxin and furosemide as a potential novel treatment approach for common warts

Tessa Niemeyer‐van der Kolk, Marlous R. Dillingh, Rianne Rijneveld et al. · Journal of the European Academy of Dermatology and Venereology · 2017 · 22 citations · Full text